Third, Rocaglamide A, a member of the flavagline class of compounds, binds to both PHB1 and PHB2 at the cell membrane to inhibit Raf activation and Raf-MEK-ERK-mediated cell cycle progression and cell proliferation in tumor cell lines, without inducing mitochondrial fragmentation [82]. The gene discussed is MAPK1; the disease is neoplasm.